Company facts
- Industry
- American Depositary Receipts
- Headquarters
- Melbourne, Victoria
- Most recent report
- 6-K, filed Aug 20, 2026
- Filings on record
- 30 filings
- On EDGAR
- CIK 1290877
- Fiscal year ends
- June
Financials 8
- 6-K Report a foreign issuer made public elsewhere Aug 20, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 12, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 30, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 28, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 27, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 23, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 22, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 22, 2026
Prospectuses and Registrations 3
Other 8 of 19
- SEC STAFF ACTION Jul 17, 2026
- CERT Exchange certified a listing Jul 17, 2026
- 20FR12B Jun 15, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Apr 17, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Mar 30, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Mar 4, 2026
- DRS Draft registration statement, submitted confidentially Dec 18, 2025
- EFFECT Notice that a registration became effective Aug 16, 2021
Everything here comes from Clinuvel Pharmaceuticals Ltd's own filings on SEC EDGAR. The filing list is rechecked every hour.